Open AccessDiscontinuation of new hepatitis C drugs among Medicare patients
Author(s) -
Jeah Jung,
Ping Du,
Roger Feldman,
Thomas Riley
Publication year - 2020
Publication title -
the american journal of managed care
Language(s) - English
Resource type - Journals
eISSN - 1936-2692
pISSN - 1088-0224
DOI - 10.37765/ajmc.2020.42397
Subject(s) - medicine , discontinuation , ombitasvir , dasabuvir , hepatitis c , odds ratio , chronic hepatitis , ribavirin , virology , virus
To examine factors associated with discontinuation of new hepatitis C drugs-second-generation direct-acting antivirals (DAAs)-among Medicare beneficiaries with chronic hepatitis C.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom